Key facts
- General Fluidics and Invetech announced a strategic collaboration.
- The partnership aims to bring fast, high-quality diagnostics closer to patients.
- The goal is to enable earlier medical decisions and broader access to care.
General Fluidics (GF) and Invetech have announced a strategic collaboration aimed at accelerating the development and deployment of fast, high-quality diagnostics at the point of care. This partnership is intended to bring diagnostic capabilities closer to patients, which could lead to earlier medical decisions, improved patient outcomes, and increased access to healthcare services. The initiative is founded on principles originating from Massachusetts General Hospital.